Sort
35,931 grants matching “parkinsons”
Exploring dopamine function during naturalistic behavior
$814,392Sandeep R Datta · Harvard Medical School · U19 · FY2022 · NS
Urate as a Predictor of Parkinson's Disease Risk and Progression
$814,371Alberto Ascherio · Harvard School Of Public Health · R01 · FY2009 · NS
Imaging epigenetic dysregulation in the Lewy body dementias with [11C]Martinostat
$814,349Stephen N. Gomperts · Massachusetts General Hospital · R01 · FY2025 · AG
Computational Tools for Research in Neuroscience, Behavioral Science and Mental H
$813,115I George Zubal · Molecular Neuroimaging, Llc · R42 · FY2013 · NS
Computational Tools for Research in Neuroscience, Behavioral Science and Mental H
$813,115I George Zubal · Molecular Neuroimaging, Llc · R42 · FY2014 · NS
RESOLVING THE CRITICAL ROLE OF PINK1 EXPRESSION AND ACTIVITY IN PARKINSON'S DISEASE PATHOPHYSIOLOGY AND THERAPEUTIC INTERVENTION
$813,085Mayo Clinic Jacksonville (A Nonprofit Corporation) · · FY2025 · Defense Health Agency
Imaging Genomics of the Aging Brain
$813,065David C Glahn · Boston Children'S Hospital · R01 · FY2021 · AG
Regulation of tau expression in Alzheimer disease and aging
$812,585John Fonda Crary · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · AG
GENETIC VARIANTS CONFERRING SUSCEPTIBILITY TO TOXICANT-INDUCED PARKINSON'S DISEASE
$811,942J.David Gladstone Institutes · · FY2024 · Defense Health Agency
Development of Novel SV2A PET Agents for Early Detection of Alzheimers Disease
$811,697Zhengxin Cai · Yale University · R01 · FY2020 · AG
Design And Development Of Experimental Therapeutics
$811,428Nigel H. Greig · National Institute On Aging · ZIA · FY2019 · AG
Natural Language Processing and Automated Speech Recognition to Identify Older Adults with Cognitive Impairment
$810,274Alex D. Federman · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · AG
GTPase function of Leucine rich repeat kinase 2
$810,235Mark Cookson · National Institute On Aging · ZIA · FY2021 · AG
Directed Evolution of Novel AAVs and Regulatory Elements for Selective Microglial Gene Expression
$810,122David V Schaffer · University Of California Berkeley · R01 · FY2023 · NS
Establishing the anatomical and functional mechanisms of white matter deep brain stimulation
$809,651Peter Rudebeck · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · MH
Analytical validation of a biochemical test for alpha-synuclein aggregates in biological fluids for the diagnosis of Parkinson's Disease
$809,593Karen Macleod · Amprion, Inc. · U44 · FY2021 · NS
Analytical validation of a biochemical test for alpha-synuclein aggregates in biological fluids for the diagnosis of Parkinson's Disease
$809,593Karen Macleod · Amprion, Inc. · U44 · FY2022 · NS
Neuroimaging Biomarkers in Parkinsonism: Differentiating Subtypes and Tracking Disease Progression
$809,543David E Vaillancourt · University Of Florida · U01 · FY2017 · NS
Mechanistic clinical trial evaluating the role of the metabotropic glutamate receptor subtype 5 (mGluR5) in the antidepressant mechanism of Cognitive Behavioral Therapy for Insomnia (CBT-I)
$808,417Christine Delorenzo · State University New York Stony Brook · R01 · FY2025 · MH
Thalamo-Cortical Plasticity: Pain, Executive Function and Loss of Dopamine
$808,372Judith Richmon Walters · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS
Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)
$808,272Dan Vlad Iosifescu · New York University School Of Medicine · R01 · FY2023 · AG
Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)
$808,272Dan Vlad Iosifescu · New York University School Of Medicine · R01 · FY2024 · AG
Clinical and Translational Core
$808,217Bradley J Willcox · Kuakini Medical Center · P20 · FY2022 · GM
Establishing the anatomical and functional mechanisms of white matter deep brain stimulation
$807,861Peter Rudebeck · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · MH
A futility trial of sirolimus in multiple system atrophy
$807,858Horacio Kaufmann · New York University School Of Medicine · R01 · FY2018 · NS